SHARE
Kinase Inhibitors Market

Kinase Inhibitors - Global Market Outlook (2019-2027)

4.4 (56 reviews)
Published: June 2020 ID: SMRC19345
4.4 (56 reviews)
Published: June 2020 ID: SMRC19345

This report covers the impact of COVID-19 on this global market

Accord ing to Stratistics MRC, the Global Kinase Inhibitors Market is accounted for $40.41 billion in 2019 and is expected to reach $64.90 billion by 2027 growing at a CAGR of 6.1% during the forecast period. Some of the key factors propelling the market growth include rise in awareness about kinase inhibitors, surge in product approvals, increase in incident of cancer diseases, and increase in investment from pharmaceutical companies. However, cost of treatment and lack of funds in conducting research are likely to restraint the market. In addition, increase in adoption of kinase inhibitors for newer applications, and emerging economies such as China, India and others, will create new opportunities for global kinase inhibitors market.

Kinase inhibitors are considered as specific enzymes that help in preventing the process of cell division and the growth of cancerous cells. These inhibitors are easy to use and are handy while treating cancer patients by blocking the signals that alert the cancer cells to grow. With the help of research and development activities in the cancer treatments, several innovations, and advanced therapeutics have been introduced. However, the results of these drugs and treatments are considered partial, palliative, and unpredictable at times. Kinase inhibitors are being highly publicized as a potential treatment for alopecia areata (AA).

By application, the oncology segment is expected to grow at the significant rate during the forecast period. Large number of approved drugs along with rich product pipeline for cancer treatment is anticipated to fuel the growth of the segment in the near future. Based on data from clinicaltrials.gov last updated on January 2020, over 75 kinase inhibitor drugs are in various phases of clinical trials for the application of oncology. On the basis of geography, North America is anticipated to have considerable market growth during the forecast period, due to rise in awareness about new drugs for treatment, availability of all major companies in the region, the introduction of new drugs, and high prevalence of cases in U.S.

Some of the key players in kinase inhibitors market include Меrсk Ѕеrоnо Ѕа, Nоvаrtіѕ Іntеrnаtіоnаl Аg, Incyte Corporation, Glaxo SmithKline, Суtrх Соrроrаtіоn, Оѕі Рhаrmасеutісаlѕ Llс, AstraZeneca, Eisai Co., Ltd., Bristol-Myers Squibb, Bayer AG, Pfizer Inc., Takeda Pharmaceutical Company Limited, Boehringer Ingelheim GmbH, Eisai Co., Ltd., Johnson & Johnson, Еtоn Віоѕсіеnсе Іnс., and F. Hoffmann-La Roche Ltd.

Types Covered:
• Receptor Tyrosine Kinase Inhibitors
• Non-receptor Tyrosine Kinase Inhibitors
• Angiogenesis Inhibitors
• Protein Kinase C Inhibitors
• RHO Kinase Inhibitors
• Multikinase inhibitors
• Serine/Threonine Kinase Inhibitors
• Tyrosin kinase inhibitors (TKI)
• Threonine kinase inhibitor
• mTOR Kinase Inhibitors
• BRAF Inhibitors
• Cyclin Dependant Kinase Inhibitor
• Aurora Kinase Inhibitors
• MAP/MEK Kinase Inhibitors
• Humanized Monoclonal Antibody
• Chimeric Monoclonal Antibody
• JNK Inhibitors
• PI3K Inhibitors
• Other Types

Distribution Channels Covered:
• Independent Pharmacies
• Hospital Pharmacies
• Online Pharmacies

Applications Covered:
• Inflammatory Diseases
• Oncology

End Users Covered:
• Scientific Research Labs
• Hospitals
• Academic Institutes
• Healthcare Facilities
• Pharmaceutical Companies
• Private and Government Research Institutes

Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o France
o Italy
o UK 
o Spain
o Rest of Europe      
• Asia Pacific
o Japan       
o China       
o India       
o Australia       
o New Zealand      
o Rest of Asia Pacific
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa

What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2018, 2019, 2020, 2024 and 2027
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic analysis: Drivers and Constraints, Product/Technology Analysis, Porter’s five forces analysis, SWOT analysis, etc.
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
o Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

1 Executive Summary    
     
2 Preface    

 2.1 Abstract   
 2.2 Stake Holders   
 2.3 Research Scope   
 2.4 Research Methodology   
  2.4.1 Data Mining  
  2.4.2 Data Analysis  
  2.4.3 Data Validation  
  2.4.4 Research Approach  
 2.5 Research Sources   
  2.5.1 Primary Research Sources  
  2.5.2 Secondary Research Sources  
  2.5.3 Assumptions  
     
3 Market Trend Analysis    
 3.1 Introduction   
 3.2 Drivers   
 3.3 Restraints   
 3.4 Opportunities   
 3.5 Threats   
 3.6 Application Analysis   
 3.7 End User Analysis   
 3.8 Emerging Markets   
 3.9 Impact of Covid-19   
     
4 Porters Five Force Analysis    
 4.1 Bargaining power of suppliers   
 4.2 Bargaining power of buyers   
 4.3 Threat of substitutes   
 4.4 Threat of new entrants   
 4.5 Competitive rivalry   
     
5 Global Kinase Inhibitors Market, By Type    
 5.1 Introduction   
 5.2 Receptor Tyrosine Kinase Inhibitors   
  5.2.1 Platelet-derived Growth Factor Receptors (PDGFR)   
  5.2.2 Vascular Endothelial Growth Factor Receptor (VEGFR)  
  5.2.3 Anaplastic lymphoma kinase (ALK)  
  5.2.4 Human Epidermal Growth Factor Receptor 2 (HER2)  
  5.2.5 Estimated Glomerular Filtration Rate (EGFR)  
 5.3 Non-receptor Tyrosine Kinase Inhibitors   
  5.3.1 Mesenchymal Epithelial Transition Growth Factor (c-MET)  
  5.3.2 Spleen Tyrosine Kinase (SYK) Inhibitors  
  5.3.3 Bruton’s Tyrosine Kinase (BTK) Inhibitors  
  5.3.4 BCR-ABL  
  5.3.5 Janus Kinase (JAK) Inhibitor  
 5.4 Angiogenesis Inhibitors   
 5.5 Protein Kinase C Inhibitors   
 5.6 RHO Kinase Inhibitors   
 5.7 Multikinase inhibitors   
 5.8 Serine/Threonine Kinase Inhibitors   
 5.9 Tyrosin kinase inhibitors (TKI)   
 5.10 Threonine kinase inhibitor   
 5.11 mTOR Kinase Inhibitors   
 5.12 BRAF Inhibitors   
 5.13 Cyclin Dependant Kinase Inhibitor   
 5.14 Aurora Kinase Inhibitors   
 5.15 MAP/MEK Kinase Inhibitors   
 5.16 Humanized Monoclonal Antibody   
 5.17 Chimeric Monoclonal Antibody   
 5.18 JNK Inhibitors   
 5.19 PI3K Inhibitors   
 5.20 Other Types   
  5.20.1 Monoclonal  Antibody Kinase Inhibitor  
     
6 Global Kinase Inhibitors Market, By Distribution Channel    
 6.1 Introduction   
 6.2 Independent Pharmacies   
 6.3 Hospital Pharmacies   
 6.4 Online Pharmacies   
     
7 Global Kinase Inhibitors Market, By Application    
 7.1 Introduction   
 7.2 Inflammatory Diseases   
 7.3 Oncology   
  7.3.1 Lung Cancer  
  7.3.2 Renal Cell Cancer  
  7.3.3 Breast Cancer  
     
8 Global Kinase Inhibitors Market, By End User 
   
 8.1 Introduction    
 8.2 Scientific Research Labs   
 8.3 Hospitals   
 8.4 Academic Institutes   
 8.5 Healthcare Facilities   
 8.6 Pharmaceutical Companies   
 8.7 Private and Government Research Institutes   
     
9 Global Kinase Inhibitors Market, By Geography  
   
 9.1 Introduction   
 9.2 North America   
  9.2.1 US  
  9.2.2 Canada  
  9.2.3 Mexico  
 9.3 Europe   
  9.3.1 Germany  
  9.3.2 UK  
  9.3.3 Italy  
  9.3.4 France  
  9.3.5 Spain  
  9.3.6 Rest of Europe  
 9.4 Asia Pacific   
  9.4.1 Japan  
  9.4.2 China  
  9.4.3 India  
  9.4.4 Australia  
  9.4.5 New Zealand  
  9.4.6 South Korea  
  9.4.7 Rest of Asia Pacific  
 9.5 South America   
  9.5.1 Argentina  
  9.5.2 Brazil  
  9.5.3 Chile  
  9.5.4 Rest of South America  
 9.6 Middle East & Africa   
  9.6.1 Saudi Arabia  
  9.6.2 UAE  
  9.6.3 Qatar  
  9.6.4 South Africa  
  9.6.5 Rest of Middle East & Africa  
     
10 Key Developments    
 10.1 Agreements, Partnerships, Collaborations and Joint Ventures   
 10.2 Acquisitions & Mergers   
 10.3 New Product Launch   
 10.4 Expansions   
 10.5 Other Key Strategies   
     
11 Company Profiling    
 11.1 Меrсk Ѕеrоnо Ѕа   
 11.2 Nоvаrtіѕ Іntеrnаtіоnаl Аg   
 11.3 Incyte Corporation   
 11.4 Glaxo SmithKline    
 11.5 Суtrх Соrроrаtіоn   
 11.6 Оѕі Рhаrmасеutісаlѕ Llс   
 11.7 AstraZeneca, Eisai Co., Ltd.   
 11.8 Bristol-Myers Squibb   
 11.9 Bayer AG   
 11.10 Pfizer Inc.   
 11.11 Takeda Pharmaceutical Company Limited   
 11.12 Boehringer Ingelheim GmbH   
 11.13 Eisai Co., Ltd.   
 11.14 Johnson & Johnson   
 11.15 Еtоn Віоѕсіеnсе Іnс.   
 11.16 F. Hoffmann-La Roche Ltd  


List of Tables     
1 Global Kinase Inhibitors Market Outlook, By Region (2018-2027) ($MN)    
2 Global Kinase Inhibitors Market Outlook, By Type (2018-2027) ($MN)    
3 Global Kinase Inhibitors Market Outlook, By Receptor Tyrosine Kinase Inhibitors (2018-2027) ($MN)    
4 Global Kinase Inhibitors Market Outlook, By Platelet-derived Growth Factor Receptors (PDGFR) (2018-2027) ($MN)    
5 Global Kinase Inhibitors Market Outlook, By Vascular Endothelial Growth Factor Receptor (VEGFR) (2018-2027) ($MN)    
6 Global Kinase Inhibitors Market Outlook, By Anaplastic lymphoma kinase (ALK) (2018-2027) ($MN)    
7 Global Kinase Inhibitors Market Outlook, By Human Epidermal Growth Factor Receptor 2 (HER2) (2018-2027) ($MN)    
8 Global Kinase Inhibitors Market Outlook, By Estimated Glomerular Filtration Rate (EGFR) (2018-2027) ($MN)    
9 Global Kinase Inhibitors Market Outlook, By Non-receptor Tyrosine Kinase Inhibitors (2018-2027) ($MN)    
10 Global Kinase Inhibitors Market Outlook, By Mesenchymal Epithelial Transition Growth Factor (c-MET) (2018-2027) ($MN)    
11 Global Kinase Inhibitors Market Outlook, By Spleen Tyrosine Kinase (SYK) Inhibitors (2018-2027) ($MN)    
12 Global Kinase Inhibitors Market Outlook, By Bruton’s Tyrosine Kinase (BTK) Inhibitors (2018-2027) ($MN)    
13 Global Kinase Inhibitors Market Outlook, By BCR-ABL (2018-2027) ($MN)    
14 Global Kinase Inhibitors Market Outlook, By Janus Kinase (JAK) Inhibitor (2018-2027) ($MN)    
15 Global Kinase Inhibitors Market Outlook, By Angiogenesis Inhibitors (2018-2027) ($MN)    
16 Global Kinase Inhibitors Market Outlook, By Protein Kinase C Inhibitors (2018-2027) ($MN)    
17 Global Kinase Inhibitors Market Outlook, By RHO Kinase Inhibitors (2018-2027) ($MN)    
18 Global Kinase Inhibitors Market Outlook, By Multikinase inhibitors (2018-2027) ($MN)    
19 Global Kinase Inhibitors Market Outlook, By Serine/Threonine Kinase Inhibitors (2018-2027) ($MN)    
20 Global Kinase Inhibitors Market Outlook, By Tyrosin kinase inhibitors (TKI) (2018-2027) ($MN)    
21 Global Kinase Inhibitors Market Outlook, By Threonine kinase inhibitor (2018-2027) ($MN)    
22 Global Kinase Inhibitors Market Outlook, By mTOR Kinase Inhibitors (2018-2027) ($MN)    
23 Global Kinase Inhibitors Market Outlook, By BRAF Inhibitors (2018-2027) ($MN)    
24 Global Kinase Inhibitors Market Outlook, By Cyclin Dependant Kinase Inhibitor (2018-2027) ($MN)    
25 Global Kinase Inhibitors Market Outlook, By Aurora Kinase Inhibitors (2018-2027) ($MN)    
26 Global Kinase Inhibitors Market Outlook, By MAP/MEK Kinase Inhibitors (2018-2027) ($MN)    
27 Global Kinase Inhibitors Market Outlook, By Humanized Monoclonal Antibody (2018-2027) ($MN)    
28 Global Kinase Inhibitors Market Outlook, By Chimeric Monoclonal Antibody (2018-2027) ($MN)    
29 Global Kinase Inhibitors Market Outlook, By JNK Inhibitors (2018-2027) ($MN)    
30 Global Kinase Inhibitors Market Outlook, By PI3K Inhibitors (2018-2027) ($MN)    
31 Global Kinase Inhibitors Market Outlook, By Other Types (2018-2027) ($MN)    
32 Global Kinase Inhibitors Market Outlook, By Monoclonal  Antibody Kinase Inhibitor (2018-2027) ($MN)    
33 Global Kinase Inhibitors Market Outlook, By Distribution Channel (2018-2027) ($MN)    
34 Global Kinase Inhibitors Market Outlook, By Independent Pharmacies (2018-2027) ($MN)    
35 Global Kinase Inhibitors Market Outlook, By Hospital Pharmacies (2018-2027) ($MN)    
36 Global Kinase Inhibitors Market Outlook, By Online Pharmacies (2018-2027) ($MN)    
37 Global Kinase Inhibitors Market Outlook, By Application (2018-2027) ($MN)    
38 Global Kinase Inhibitors Market Outlook, By Inflammatory Diseases (2018-2027) ($MN)    
39 Global Kinase Inhibitors Market Outlook, By Oncology (2018-2027) ($MN)    
40 Global Kinase Inhibitors Market Outlook, By Lung Cancer (2018-2027) ($MN)    
41 Global Kinase Inhibitors Market Outlook, By Renal Cell Cancer (2018-2027) ($MN)    
42 Global Kinase Inhibitors Market Outlook, By Breast Cancer (2018-2027) ($MN)    
43 Global Kinase Inhibitors Market Outlook, By End User (2018-2027) ($MN)    
44 Global Kinase Inhibitors Market Outlook, By Scientific Research Labs (2018-2027) ($MN)    
45 Global Kinase Inhibitors Market Outlook, By Hospitals (2018-2027) ($MN)    
46 Global Kinase Inhibitors Market Outlook, By Academic Institutes (2018-2027) ($MN)    
47 Global Kinase Inhibitors Market Outlook, By Healthcare Facilities (2018-2027) ($MN)    
48 Global Kinase Inhibitors Market Outlook, By Pharmaceutical Companies (2018-2027) ($MN)    
49 Global Kinase Inhibitors Market Outlook, By Private and Government Research Institutes (2018-2027) ($MN)    
     
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.     

In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929

Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.

Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.

All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929

We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.

We have 3 different licensing options available in electronic format.

  • Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
  • 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
  • Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.

All our reports are typically be emailed to you as an attachment.

To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards.

We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.

We provide a free 15% customization on every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.

Note: This customization is absolutely free until it falls under the 15% bracket. If your requirement exceeds this a feasibility check will be performed. Post that, a quote will be provided along with the timelines.

Select License Type

Allows one person to have access to the ordered product.The ordered product cannot be distributed to anyone else.
Allows the ordered product to be shared among a maximum of 5 people within your organisation.
Allows the product to be shared among all employees of your organisation at one particular location.
Allows the product to be shared among all employees of your organisation regardless of their geographical location.

WHY CHOOSE US ?

Assured Quality

Assured Quality

Best in class reports with high standard of research integrity

24X7 Research Support

24X7 Research Support

Continuous support to ensure the best customer experience.

Free Customization

Free Customization

Adding more values to your product of interest.

Safe and Secure Access

Safe & Secure Access

Providing a secured environment for all online transactions.

Trusted by 600+ Brands

Trusted by 600+ Brands

Serving the most reputed brands across the world.

Testimonials